What is Brief History of FIGS Company?

GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
FIGS

Full Company Analysis:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10

TOTAL:

How did FIGS reinvent medical apparel?

FIGS upended a stagnant healthcare apparel market in 2013 by applying athletic-wear technology to scrubs, creating Technical Comfort and turning uniforms into a lifestyle choice. The brand scaled rapidly from Los Angeles to a global direct-to-consumer presence.

What is Brief History of FIGS Company?

FIGS transformed scratchy, utilitarian scrubs into high-performance uniforms, helping it capture a share of a global market valued at over $85 billion in 2025 and expand into 20+ countries with industry-leading gross margins near 70%.

What is Brief History of FIGS Company? FIGS launched in 2013, introduced proprietary fabric tech, grew to millions of customers, listed on the NYSE, and shifted medical apparel from commodity to community-driven brand — see FIGS Porter's Five Forces Analysis.

What is the FIGS Founding Story?

Founding Story: In 2013 Heather Hasson and Trina Spear launched FIGS to modernize medical apparel by applying performance fabric and DTC e-commerce to scrubs, starting from car-trunk sales and scaling to institutional and retail channels.

Icon

Founding Story

FIGS company history began in 2013 when a design-minded founder saw an opportunity to replace boxy, outdated scrubs with tailored, technical apparel and a direct-to-consumer model.

  • Founders of FIGS: Heather Hasson (fashion entrepreneur) and Trina Spear (Harvard Business School, former Blackstone analyst)
  • When was FIGS founded: 2013; early growth included selling scrubs from car trunks at hospital shift changes
  • Initial product: FIONx fabric with four-way stretch, moisture-wicking and antimicrobial features; tailored fit versus sack-like scrubs
  • Funding milestones: bootstrapped start, seed rounds followed by a $65,000,000 investment from Viking Global Investors in 2018 as DTC scrubs gained investor interest

Key milestones in the history of FIGS include the 2013 founding, rapid DTC growth, institutional channel expansion, and capital raises that supported scaling toward a public listing; see further market context in Target Market of FIGS.

Complete FIGS Strategy Bundle

  • 6 Full Frameworks, 1 Company – All Pre-Researched
  • Each Framework Fully Sourced with Real Company Data
  • Built for Strategy Courses, Case Studies & MBA Programs
  • Adapt to Your Assignment – No Starting from Scratch
  • 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's
Get Related Template

What Drove the Early Growth of FIGS?

Following its 2013 launch, FIGS rapidly scaled by targeting individual healthcare professionals and using social media and influencer marketing to build a loyal ambassador community, driving strong repeat purchases and brand visibility.

Icon Community-led growth

FIGS focused on individual clinicians rather than hospital procurement, creating ambassador-driven word‑of‑mouth that amplified early adoption across nursing and physician networks.

Icon Rapid revenue acceleration

Between 2017 and 2020 FIGS recorded revenue growth at a compound annual growth rate exceeding 100%, reflecting explosive demand for premium scrubs and direct-to-consumer distribution.

Icon Product iteration and AOV lift

Key product iterations—limited‑edition color drops, outerwear, underscrubs and compression socks—increased average order value and customer lifetime value as workers wore FIGS on and off duty.

Icon Capital and public listing

Capital raises culminated in a 2021 IPO that raised $580,000,000, valuing the company at roughly $4.4 billion at its peak and marking the first female‑founded public company led by two female co‑CEOs.

Geographic expansion into Canada, the UK and Australia, plus the launch of the TEAMS institutional portal, diversified channels; by 2025 TEAMS represents a double‑digit percentage of total revenue and complements the direct consumer business.

Growth Strategy of FIGS

From PESTLE Factors to Full Strategy Bundle

  • PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
  • Every Strategic Angle Covered – Nothing Left to Research
  • Pre-filled with Company-Specific Research
  • No Missing Sections for Your Case Study
  • One Download Covers Your Entire Company Analysis
Get Related Template

What are the key Milestones in FIGS history?

FIGS company history includes product innovation with FIONx fabric and Silvadur tech, legal wins in 2023–2024, strategic partnerships with New Balance and Olympic medical teams, a 2024 operational pivot to retail Community Hubs, and international expansion into the Middle East and Southeast Asia by 2025.

Year Milestone
2013 Founders launched the company to modernize medical apparel, beginning the FIGS company timeline with direct-to-consumer sales.
2018 Reached IPO milestone and scaled nationwide distribution and marketing channels.
2023 Secured major legal victories defending marketing claims against legacy competitors, reinforcing transparency and quality.
2024 Optimized marketing spend and inventory amid post-pandemic supply chain volatility and shifting consumer habits.
2024 Announced strategic partnership with New Balance for specialized medical footwear and designation as official outfitter for several Olympic medical teams.
2025 Opened Community Hubs in Los Angeles and Philadelphia and expanded into the Middle East and Southeast Asia, adapting product designs to local markets.

FIGS pioneered its proprietary FIONx fabric and integrated Silvadur antimicrobial treatment across its product line, improving durability and hygiene performance for clinical settings. By 2025 the company reported international revenue growth contributing to a double-digit percentage of total sales while maintaining a debt-free balance sheet.

Icon

FIONx Performance Fabric

FIONx delivers stretch, breathability and wrinkle resistance tailored for healthcare workflows, reducing garment replacements and improving clinician comfort.

Icon

Silvadur Antimicrobial Integration

Silvadur technology was applied across the product line to inhibit microbial growth and extend garment life in clinical environments.

Icon

Footwear Collaboration

Collaboration with New Balance produced specialized medical footwear addressing comfort and slip-resistance needs for long shifts.

Icon

Community Hubs Retail Model

Physical Community Hubs combine retail, fittings and professional networking, enhancing brand loyalty and local engagement.

Icon

Transparency and Legal Outcomes

Legal victories in 2023–2024 clarified permissible marketing claims and strengthened consumer trust in product performance statements.

Icon

International Design Adaptation

Design changes addressed cultural and sizing requirements for markets in the Middle East and Southeast Asia, facilitating local adoption.

FIGS faced supply chain volatility and shifting post-pandemic consumer spending that reduced demand elasticity and pressured gross margins in 2024. Leadership streamlined decision-making under Trina Spear as sole CEO and tightened inventory management to restore margin stability.

Icon

Supply Chain Volatility

Global material shortages and shipping delays in 2022–2024 forced higher safety stock and increased logistics costs, prompting more regional sourcing and vendor consolidation.

Icon

Consumer Spending Shifts

Post-pandemic spending trends reduced discretionary apparel purchases, requiring FIGS to optimize marketing ROI and promotions to preserve unit economics.

Icon

Inventory Optimization

2024 inventory rationalization reduced aged stock and improved turns, enabling a leaner balance sheet and maintaining a debt-free position.

Icon

Leadership Transition

Consolidation of CEO responsibilities under Trina Spear aimed to accelerate international scaling and speed strategic decisions.

Icon

Retail Execution Risks

Pivoting to physical Community Hubs increased fixed costs and required careful site economics to ensure positive unit economics per location.

Icon

Regulatory and Cultural Adaptation

Expanding into new regions necessitated compliance with local textile regulations and culturally appropriate product modifications to meet customer expectations.

For more on the company’s commercial model and revenue composition see Revenue Streams & Business Model of FIGS.

FIGS Business Model + Strategy Bundle

  • Ideal for Essays, Case Studies & Slides
  • Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
  • Company-Specific Content Already Organized
  • One Bundle Replaces Days of Independent Research
  • Buy the Bundle Once. Use Across All Your Assignments
Get Related Template

What is the Timeline of Key Events for FIGS?

Timeline and Future Outlook: The FIGS company history traces rapid e-commerce scaling, institutional expansion, international growth, and product diversification from its 2013 founding toward a projected $750,000,000 in annual net revenue by 2026.

Year Key Event
2013 FIGS is founded in Los Angeles by Heather Hasson and Trina Spear, launching a direct-to-consumer medical apparel brand.
2016 Completed a $5,000,000 Series A round to scale e-commerce operations and supply chain capabilities.
2018 Received a $65,000,000 investment from Viking Global Investors to accelerate growth and product development.
2021 Completed an Initial Public Offering on the NYSE under the ticker FIGS, providing capital for expansion.
2022 Launched the FIGS TEAMS platform to pursue institutional B2B sales and enterprise partnerships.
2023 Opened the first permanent physical retail Community Hub in Century City to deepen customer engagement.
2024 Expanded international footprint to 15 countries, including Mexico and the UAE, increasing global distribution.
2025 Introduced the FIGS PRO collection, a high-performance line tailored for surgical environments and procedural clinicians.
2026 Projected achievement of $750,000,000 in annual net revenue based on current growth trajectories and expanded product mix.
Icon Institutional B2B Growth

FIGS TEAMS targets hospitals and health systems, with enterprise contracts and bulk ordering expected to drive a growing share of revenue over the next 3–5 years.

Icon International Expansion

Presence in 15 countries as of 2024 establishes distribution channels in Latin America and the Middle East, supporting continued international revenue growth.

Icon Product Diversification

Expansion into footwear, specialized medical gear, and smart-textiles is projected to increase average order value and margins, with FIGS PRO as a catalyst.

Icon Community and Retail Strategy

Physical hubs like Century City deepen brand loyalty and serve as testing grounds for omnichannel initiatives and localized merchandising.

Mission, Vision & Core Values of FIGS

From Five Forces to Full Company Analysis

  • Includes SWOT, PESTLE, BMC, BCG and 4P's
  • Pre-Researched with Company-Specific Data
  • Best Value for a Complete Analysis
  • Ready to Adapt for Your Case Study
  • Ready for Essays and Slidesd
Get Related Template

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.